LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
Authors
Keywords
-
Journal
Translational Neurodegeneration
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-31
DOI
10.1186/s40035-022-00281-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
- (2021) Tapan Behl et al. Translational Neurodegeneration
- Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
- (2021) Roberto A. Ortega et al. JAMA Network Open
- Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models
- (2021) Tetsuro Abe et al. Frontiers in Neurology
- A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
- (2021) Mali Cosden et al. NEUROBIOLOGY OF DISEASE
- Autophagy in Parkinson's Disease
- (2020) Xu Hou et al. JOURNAL OF MOLECULAR BIOLOGY
- Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
- (2020) Susanne A. Schneider et al. JOURNAL OF NEUROLOGY
- Lysosome and Inflammatory Defects in GBA1 ‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition
- (2020) Anwesha Sanyal et al. MOVEMENT DISORDERS
- Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations
- (2020) Stephen Mullin et al. JAMA Neurology
- Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
- (2020) Thomas B Stoker et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease
- (2020) Nurit Omer et al. MOVEMENT DISORDERS
- LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
- (2020) Marco A. S. Baptista et al. Science Translational Medicine
- LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons
- (2020) Anwesha Sanyal et al. Frontiers in Neuroscience
- “LRRK2: Autophagy and Lysosomal Activity”
- (2020) Marta Madureira et al. Frontiers in Neuroscience
- Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions
- (2020) Julia Obergasteiger et al. Cell Death Discovery
- Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction
- (2020) C. K. Deniston et al. NATURE
- Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers
- (2020) M. Judith Peterschmitt et al. Clinical Pharmacology in Drug Development
- Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to Therapy
- (2020) Ana Belen Malpartida et al. TRENDS IN BIOCHEMICAL SCIENCES
- Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
- (2020) Tanya Simuni et al. JAMA Neurology
- Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)
- (2019) Philip Wing-Lok Ho et al. Autophagy
- LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
- (2019) Rebecca Wallings et al. HUMAN MOLECULAR GENETICS
- GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
- (2019) Giulietta M. Riboldi et al. Cells
- Recent Developments in LRRK2-Targeted Therapy for Parkinson’s Disease
- (2019) Ye Zhao et al. DRUGS
- Glucocerebrosidase and its relevance to Parkinson disease
- (2019) Jenny Do et al. Molecular Neurodegeneration
- Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson’s disease
- (2019) Akanksha Mishra et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
- (2019) Orly Goldstein et al. MOLECULAR GENETICS AND METABOLISM
- Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein
- (2019) Leah K. Cuddy et al. NEURON
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients
- (2019) Daniel Ysselstein et al. Nature Communications
- Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
- (2018) Elena Kozina et al. BRAIN
- Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons
- (2018) Jason Schapansky et al. NEUROBIOLOGY OF DISEASE
- The Changing Landscape of Parkinson Epidemiologic Research
- (2018) Honglei Chen Journal of Parkinsons Disease
- Mitochondrial Dysfunction and Mitophagy Defect Triggered by Heterozygous GBA Mutations
- (2018) Hongyu Li et al. Autophagy
- Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
- (2018) Anna Lisa Gündner et al. NEUROBIOLOGY OF DISEASE
- LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
- (2018) Tomoya Eguchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LRRK2 activation in idiopathic Parkinson’s disease
- (2018) Roberto Di Maio et al. Science Translational Medicine
- LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
- (2018) Eun-Jin Bae et al. Nature Communications
- Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations
- (2018) Gilad Yahalom et al. PARKINSONISM & RELATED DISORDERS
- GBA mutations in Parkinson disease: earlier death but similar neuropathological features
- (2017) C. H. Adler et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease
- (2017) Camilla P. da Silva et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A “dose” effect of mutations in the GBA gene on Parkinson's disease phenotype
- (2017) Avner Thaler et al. PARKINSONISM & RELATED DISORDERS
- Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models
- (2017) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
- (2017) Hui-Fang Liu et al. Scientific Reports
- Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice
- (2016) Anna Migdalska-Richards et al. ANNALS OF NEUROLOGY
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein
- (2016) G. Guaitoli et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models
- (2016) Chunhe Su et al. BRAIN RESEARCH
- Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
- (2016) Joana Magalhaes et al. HUMAN MOLECULAR GENETICS
- Neuropsychiatric characteristics of GBA-associated Parkinson disease
- (2016) Matthew Swan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
- (2016) Martin Steger et al. eLife
- ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
- (2016) Hugo J.R. Fernandes et al. Stem Cell Reports
- Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
- (2015) Ziv Gan-Or et al. Autophagy
- Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations
- (2015) Roy N. Alcalay et al. BRAIN
- Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
- (2015) Davide Chiasserini et al. Molecular Neurodegeneration
- Cognitive profile ofLRRK2-related Parkinson's disease
- (2015) Sindhu Srivatsal et al. MOVEMENT DISORDERS
- Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
- (2015) Tomoko Oeda et al. NEUROBIOLOGY OF AGING
- Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells
- (2015) Giulia Ambrosi et al. NEUROBIOLOGY OF DISEASE
- Differential effects of severe vs mild GBA mutations on Parkinson disease
- (2015) Z. Gan-Or et al. NEUROLOGY
- Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A , tau, and -synuclein
- (2015) M. Goedert SCIENCE
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- Motor phenotype of LRRK2-associated Parkinson's disease: A tunisian longitudinal study
- (2014) Fatma Nabli et al. MOVEMENT DISORDERS
- GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
- (2014) Kathrin Brockmann et al. MOVEMENT DISORDERS
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis
- (2014) David C. Schöndorf et al. Nature Communications
- LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
- (2014) Hui-Fang Liu et al. Annals of Clinical and Translational Neurology
- Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
- (2013) M. L. Hebron et al. HUMAN MOLECULAR GENETICS
- Parkinson disease phenotype in Ashkenazi jews with and withoutLRRK2G2019S mutations
- (2013) Roy N. Alcalay et al. MOVEMENT DISORDERS
- Interplay of LRRK2 with chaperone-mediated autophagy
- (2013) Samantha J Orenstein et al. NATURE NEUROSCIENCE
- A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism
- (2013) Joanne Trinh et al. NEUROBIOLOGY OF AGING
- RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk
- (2013) David A. MacLeod et al. NEURON
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
- (2012) José M. Bravo-San Pedro et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
- (2012) Adriana Sánchez-Danés et al. EMBO Molecular Medicine
- A clinical and family history study of Parkinson's disease in heterozygousglucocerebrosidasemutation carriers
- (2012) Alisdair McNeill et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The link between the GBA gene and parkinsonism
- (2012) Ellen Sidransky et al. LANCET NEUROLOGY
- Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study
- (2012) R. N. Alcalay et al. NEUROLOGY
- Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
- (2012) Z. Sheng et al. Science Translational Medicine
- Microautophagy in mammalian cells: Revisiting a 40-year-old conundrum
- (2011) Dalibor Mijaljica et al. Autophagy
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
- (2011) Martin C. Herzig et al. HUMAN MOLECULAR GENETICS
- Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP
- (2011) Patricia Gómez-Suaga et al. HUMAN MOLECULAR GENETICS
- The enigma of the E326K mutation in acid β-glucocerebrosidase
- (2011) Mia Horowitz et al. MOLECULAR GENETICS AND METABOLISM
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- GBA-associated PD presents with nonmotor characteristics
- (2011) K. Brockmann et al. NEUROLOGY
- Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers
- (2011) C. Marras et al. NEUROLOGY
- Cognitive dysfunction in Tunisian LRRK2 associated Parkinson’s disease
- (2011) Samia Ben Sassi et al. PARKINSONISM & RELATED DISORDERS
- TFEB Links Autophagy to Lysosomal Biogenesis
- (2011) C. Settembre et al. SCIENCE
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
- (2010) Ozlem Goker-Alpan et al. ACTA NEUROPATHOLOGICA
- Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
- (2010) Lydia Alvarez-Erviti et al. ARCHIVES OF NEUROLOGY
- The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
- (2010) Barry Rosenbloom et al. BLOOD CELLS MOLECULES AND DISEASES
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Termination of autophagy and reformation of lysosomes regulated by mTOR
- (2010) Li Yu et al. NATURE
- LRRK2 G2019S mutation in Parkinson’s disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
- (2010) Soreya Belarbi et al. PARKINSONISM & RELATED DISORDERS
- Chaperone-mediated autophagy: Molecular mechanisms and physiological relevance
- (2010) Samantha J. Orenstein et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
- (2008) Edward D. Plowey et al. JOURNAL OF NEUROCHEMISTRY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
- Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
- (2008) W. C. Nichols et al. NEUROLOGY
- Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
- (2008) Z. Gan-Or et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started